Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey
Open Access
- 21 October 2005
- Vol. 61 (1), 34-40
- https://doi.org/10.1136/thx.2005.040881
Abstract
Background: Hormone replacement therapy (HRT) and obesity both appear to increase the risk of asthma. A study was undertaken to investigate the association of HRT with asthma and hay fever in a population of perimenopausal women, focusing on a possible interaction with body mass index (BMI). Methods: A postal questionnaire was sent to population based samples in Denmark, Estonia, Iceland, Norway, and Sweden in 1999–2001, and 8588 women aged 25–54 years responded (77%). Pregnant women, women using oral contraceptives, and women Results: HRT was associated with an increased risk for asthma (OR 1.57 (95% CI 1.07 to 2.30)), wheeze (OR 1.60 (95% CI 1.22 to 2.10)), and hay fever (OR 1.48 (95% CI 1.15 to 1.90)). The associations with asthma and wheeze were significantly stronger among women with BMI in the lower tertile (asthma OR 2.41 (95% CI 1.21 to 4.77); wheeze OR 2.04 (95% CI 1.23 to 3.36)) than in heavier women (asthma: pinteraction = 0.030; wheeze: pinteraction = 0.042). Increasing BMI was associated with more asthma (OR 1.08 (95% CI 1.05 to 1.12) per kg/m2). This effect was only found in women not taking HRT (OR 1.10 (95% CI 1.05 to 1.14) per kg/m2); no such association was detected in HRT users (OR 1.00 (95% CI 0.92 to 1.08) per kg/m2) (pinteraction = 0.046). Menopause was not significantly associated with asthma, wheeze, or hay fever. Conclusions: In perimenopausal women there is an interaction between HRT and BMI in the effects on asthma. Lean women who were HRT users had as high a risk for asthma as overweight women not taking HRT. It is suggested that HRT and overweight increase the risk of asthma through partly common pathways.Keywords
This publication has 37 references indexed in Scilit:
- Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention TrialJournal of Clinical Endocrinology & Metabolism, 2003
- CD14 Monocyte Receptor, Involved in the Inflammatory Cascade, and Insulin SensitivityJournal of Clinical Endocrinology & Metabolism, 2003
- Understanding the Divergent Data on Postmenopausal Hormone TherapyNew England Journal of Medicine, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Body Composition Modulates the Effects of Hormone Replacement Therapy on Growth Hormone and Insulin-Like Growth Factor-I Levels in Postmenopausal WomenGynecologic and Obstetric Investigation, 2002
- Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women.2001
- Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general populationThorax, 2001
- Asthma and sex hormonesAllergy, 2001
- Self-defined menopausal status in a multi-ethnic sample of midlife womenMaturitas, 2000
- The Role of Local Estrogen Biosynthesis in Males and FemalesTrends in Endocrinology & Metabolism, 2000